Home › Chronic Lymphocytic Leukemia › Georgia › South Fulton
Chronic Lymphocytic Leukemia clinical trials in South Fulton, GA
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around South Fulton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Southeastern Regional Medical Center, Newnan · 16 mi away
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RecruitingPhase 1/2
- City of Hope - Atlanta, Newnan · 16 mi away
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RecruitingPhase 2
- City of Hope National Medical Center, Atlanta Cancer Center, Newnan · 16 mi away
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
RecruitingPhase 2
- City of Hope Atlanta Cancer Center, Newnan · 16 mi away
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN18 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
- Cincinnati, OH14 studies
Other studies in South Fulton
- Obesity12 studies
- Overweight11 studies
- Non-Small Cell Lung Cancer8 studies
- Type 2 Diabetes7 studies
- Lung Cancer7 studies
- Breast Cancer5 studies
- Colorectal Cancer4 studies
- Heart Failure4 studies
- Cancer (all types)3 studies
- Prostate Cancer3 studies
- Multiple Myeloma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.